Document Detail

A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution.
MedLine Citation:
PMID:  19886316     Owner:  NLM     Status:  MEDLINE    
Encapsulating peritoneal sclerosis (EPS) is an intestinal obstruction syndrome in which peritoneal deterioration and intraperitoneal inflammation result in intestinal adhesions, which are covered with a fibrin capsule and which cause bowel obstruction. Here, we report the case of a patient with EPS suspected to result from the use of icodextrin peritoneal solution. In this patient, peritoneal permeability to high molecular weight solutes and effluent interleukin-6 (IL-6) levels increased after initiation on-to icodextrin solution. The patient developed symptoms of intestinal obstruction accompanied by intestinal edema 30 months after the start of icodextrin and after a peritoneal dialysis (PD) duration of 78 months. He was then diagnosed as being in a pre-EPS state. The use of icodextrin solution was discontinued, and the symptoms of intestinal obstruction improved after corticosteroid administration. Subsequently, he was managed on a combination of PD using glucose solution low in glucose degradation products and of twice-weekly hemodialysis, but he showed enhanced peritoneal permeability and increases in effluent IL-6. After a PD period of 98 months, severe symptoms of intestinal obstruction developed, and enterolysis was performed. The degeneration of the intestinal wall itself was slight, and the adhesions between the capsule and intestinal surface could be readily removed. In this patient, the degree of peritoneal deterioration and capsule formation differed from that of typical EPS. These findings suggest the promotion of capsule formation by icodextrin solution and the involvement of certain inflammatory reactions.
Hideki Kawanishi; Sadanori Shintaku; Masayuki Shishida; Misaki Morrishi; Shinichiro Tsuchiya; Kiyohiko Dohi
Related Documents :
2036856 - Complications of percutaneous dart therapy in management of pneumothorax.
18474916 - Gastric acid suppression and the risk of enteric peritonitis in peritoneal dialysis pat...
9260536 - Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal di...
2681926 - Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions.
1734706 - Diplopia and diarrhea: ileal carcinoid metastatic to the central nervous system.
20011096 - Vitamin d deficiency-a clinical spectrum: is there a symptomatic nonosteomalacic state?
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Advances in peritoneal dialysis. Conference on Peritoneal Dialysis     Volume:  25     ISSN:  1197-8554     ISO Abbreviation:  Adv Perit Dial     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-05     Completed Date:  2009-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104803     Medline TA:  Adv Perit Dial     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  45-9     Citation Subset:  IM    
Tsuchiya General Hospital, Hiroshima, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Glucans / adverse effects*
Glucose / adverse effects*
Hemodialysis Solutions / adverse effects*
Interleukin-6 / metabolism
Intestinal Obstruction / etiology
Middle Aged
Peritoneal Dialysis*
Peritoneal Fibrosis / chemically induced*,  diagnosis,  metabolism,  therapy
Peritoneum / metabolism
Permeability / drug effects
Reg. No./Substance:
0/Glucans; 0/Hemodialysis Solutions; 0/Interleukin-6; 0/icodextrin; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Peritoneal dialysis patients with high effluent fibrin degradation products.
Next Document:  Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory ...